A citation-based method for searching scientific literature

Erin D Pleasance, R Keira Cheetham, Philip J Stephens, David J McBride, Sean J Humphray, Chris D Greenman, Ignacio Varela, Meng-Lay Lin, Gonzalo R Ordóñez, Graham R Bignell, Kai Ye, Julie Alipaz, Markus J Bauer, David Beare, Adam Butler, Richard J Carter, Lina Chen, Anthony J Cox, Sarah Edkins, Paula I Kokko-Gonzales, Niall A Gormley, Russell J Grocock, Christian D Haudenschild, Matthew M Hims, Terena James, Mingming Jia, Zoya Kingsbury, Catherine Leroy, John Marshall, Andrew Menzies, Laura J Mudie, Zemin Ning, Tom Royce, Ole B Schulz-Trieglaff, Anastassia Spiridou, Lucy A Stebbings, Lukasz Szajkowski, Jon Teague, David Williamson, Lynda Chin, Mark T Ross, Peter J Campbell, David R Bentley, P Andrew Futreal, Michael R Stratton. Nature 2010
Times Cited: 1163







List of co-cited articles
669 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Coming of age: ten years of next-generation sequencing technologies.
Sara Goodwin, John D McPherson, W Richard McCombie. Nat Rev Genet 2016
3

Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations.
Jesse J Salk, Michael W Schmitt, Lawrence A Loeb. Nat Rev Genet 2018
223
3

Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas.
Michael Krauthammer, Yong Kong, Antonella Bacchiocchi, Perry Evans, Natapol Pornputtapong, Cen Wu, Jamie P. McCusker, Shuangge Ma, Elaine Cheng, Robert Straub,[...]. Nat Genet 2015
232
3

Germline mutations in BAP1 predispose to melanocytic tumors.
Thomas Wiesner, Anna C Obenauf, Rajmohan Murali, Isabella Fried, Klaus G Griewank, Peter Ulz, Christian Windpassinger, Werner Wackernagel, Shea Loy, Ingrid Wolf,[...]. Nat Genet 2011
472
3

TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
3

Putting p53 in Context.
Edward R Kastenhuber, Scott W Lowe. Cell 2017
811
3

The impact of translocations and gene fusions on cancer causation.
Felix Mitelman, Bertil Johansson, Fredrik Mertens. Nat Rev Cancer 2007
892
3

Analyses of non-coding somatic drivers in 2,658 cancer whole genomes.
Esther Rheinbay, Morten Muhlig Nielsen, Federico Abascal, Jeremiah A Wala, Ofer Shapira, Grace Tiao, Henrik Hornshøj, Julian M Hess, Randi Istrup Juul, Ziao Lin,[...]. Nature 2020
207
3

Genome-wide analysis of human global and transcription-coupled excision repair of UV damage at single-nucleotide resolution.
Jinchuan Hu, Sheera Adar, Christopher P Selby, Jason D Lieb, Aziz Sancar. Genes Dev 2015
149
3

Mutational Strand Asymmetries in Cancer Genomes Reveal Mechanisms of DNA Damage and Repair.
Nicholas J Haradhvala, Paz Polak, Petar Stojanov, Kyle R Covington, Eve Shinbrot, Julian M Hess, Esther Rheinbay, Jaegil Kim, Yosef E Maruvka, Lior Z Braunstein,[...]. Cell 2016
219
3

Diverse mechanisms of somatic structural variations in human cancer genomes.
Lixing Yang, Lovelace J Luquette, Nils Gehlenborg, Ruibin Xi, Psalm S Haseley, Chih-Heng Hsieh, Chengsheng Zhang, Xiaojia Ren, Alexei Protopopov, Lynda Chin,[...]. Cell 2013
213
3

Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples.
Kristian Cibulskis, Michael S Lawrence, Scott L Carter, Andrey Sivachenko, David Jaffe, Carrie Sougnez, Stacey Gabriel, Matthew Meyerson, Eric S Lander, Gad Getz. Nat Biotechnol 2013
3

Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution.
S Kasar, J Kim, R Improgo, G Tiao, P Polak, N Haradhvala, M S Lawrence, A Kiezun, S M Fernandes, S Bahl,[...]. Nat Commun 2015
132
3

Passenger hotspot mutations in cancer driven by APOBEC3A and mesoscale genomic features.
Rémi Buisson, Adam Langenbucher, Danae Bowen, Eugene E Kwan, Cyril H Benes, Lee Zou, Michael S Lawrence. Science 2019
119
3

An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers.
Steven A Roberts, Michael S Lawrence, Leszek J Klimczak, Sara A Grimm, David Fargo, Petar Stojanov, Adam Kiezun, Gregory V Kryukov, Scott L Carter, Gordon Saksena,[...]. Nat Genet 2013
739
3

The molecular profile of mucosal melanoma.
Lauge Hjorth Mikkelsen, Emil Maag, Mette Klarskov Andersen, Mogens Kruhøffer, Ann-Cathrine Larsen, Linea Cecilie Melchior, Peter Bjerre Toft, Christian von Buchwald, Karin Wadt, Steffen Heegaard. Melanoma Res 2020
10
30

Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial.
Frank Stephen Hodi, Vanna Chiarion-Sileni, Rene Gonzalez, Jean-Jacques Grob, Piotr Rutkowski, Charles Lance Cowey, Christopher D Lao, Dirk Schadendorf, John Wagstaff, Reinhard Dummer,[...]. Lancet Oncol 2018
695
3

Nivolumab in previously untreated melanoma without BRAF mutation.
Caroline Robert, Georgina V Long, Benjamin Brady, Caroline Dutriaux, Michele Maio, Laurent Mortier, Jessica C Hassel, Piotr Rutkowski, Catriona McNeil, Ewa Kalinka-Warzocha,[...]. N Engl J Med 2015
3

Pembrolizumab versus Ipilimumab in Advanced Melanoma.
Caroline Robert, Jacob Schachter, Georgina V Long, Ana Arance, Jean Jacques Grob, Laurent Mortier, Adil Daud, Matteo S Carlino, Catriona McNeil, Michal Lotem,[...]. N Engl J Med 2015
3

Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.
A Gordon Robertson, Juliann Shih, Christina Yau, Ewan A Gibb, Junna Oba, Karen L Mungall, Julian M Hess, Vladislav Uzunangelov, Vonn Walter, Ludmila Danilova,[...]. Cancer Cell 2017
399
3

Conjunctival melanoma in the Netherlands: a nationwide study.
Guy S Missotten, Sander Keijser, Rob J W De Keizer, Didi De Wolff-Rouendaal. Invest Ophthalmol Vis Sci 2005
135
3

Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial.
Paolo A Ascierto, Grant A McArthur, Brigitte Dréno, Victoria Atkinson, Gabrielle Liszkay, Anna Maria Di Giacomo, Mario Mandalà, Lev Demidov, Daniil Stroyakovskiy, Luc Thomas,[...]. Lancet Oncol 2016
547
3

The Role of PTEN Loss in Immune Escape, Melanoma Prognosis and Therapy Response.
Rita Cabrita, Shamik Mitra, Adriana Sanna, Henrik Ekedahl, Kristina Lövgren, Håkan Olsson, Christian Ingvar, Karolin Isaksson, Martin Lauss, Ana Carneiro,[...]. Cancers (Basel) 2020
13
23

NF1 mutations in conjunctival melanoma.
S L Scholz, I Cosgarea, D Süßkind, R Murali, I Möller, H Reis, S Leonardelli, B Schilling, T Schimming, E Hadaschik,[...]. Br J Cancer 2018
42
7

Immunotherapy With Programmed Cell Death 1 Inhibitors for 5 Patients With Conjunctival Melanoma.
Oded Sagiv, Sudip D Thakar, Thomas J Kandl, Joshua Ford, Matthew C Sniegowski, Wen-Jen Hwu, Bita Esmaeli. JAMA Ophthalmol 2018
46
6

Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas.
Klaus G Griewank, Henrike Westekemper, Rajmohan Murali, Monika Mach, Bastian Schilling, Thomas Wiesner, Tobias Schimming, Elisabeth Livingstone, Antje Sucker, Florian Grabellus,[...]. Clin Cancer Res 2013
130
3


Prognostic value of clinical and histopathological parameters in conjunctival melanomas: a retrospective study.
Gerasimos Anastassiou, Arnd Heiligenhaus, Nikos Bechrakis, Elisabeth Bader, Norbert Bornfeld, Klaus-Peter Steuhl. Br J Ophthalmol 2002
88
3

TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours.
K G Griewank, R Murali, B Schilling, S Scholz, A Sucker, M Song, D Süsskind, F Grabellus, L Zimmer, U Hillen,[...]. Br J Cancer 2013
84
3

Melanoma subtypes: genomic profiles, prognostic molecular markers and therapeutic possibilities.
Roy Rabbie, Peter Ferguson, Christian Molina-Aguilar, David J Adams, Carla D Robles-Espinoza. J Pathol 2019
75
4

Current State of Target Treatment in BRAF Mutated Melanoma.
Enrica Teresa Tanda, Irene Vanni, Andrea Boutros, Virginia Andreotti, William Bruno, Paola Ghiorzo, Francesco Spagnolo. Front Mol Biosci 2020
30
10

Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma.
Caroline Robert, Jean J Grob, Daniil Stroyakovskiy, Boguslawa Karaszewska, Axel Hauschild, Evgeny Levchenko, Vanna Chiarion Sileni, Jacob Schachter, Claus Garbe, Igor Bondarenko,[...]. N Engl J Med 2019
487
3

International network of cancer genome projects.
Thomas J Hudson, Warwick Anderson, Axel Artez, Anna D Barker, Cindy Bell, Rosa R Bernabé, M K Bhan, Fabien Calvo, Iiro Eerola, Daniela S Gerhard,[...]. Nature 2010
3


An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers.
Kin Chan, Steven A Roberts, Leszek J Klimczak, Joan F Sterling, Natalie Saini, Ewa P Malc, Jaegil Kim, David J Kwiatkowski, David C Fargo, Piotr A Mieczkowski,[...]. Nat Genet 2015
225
3


Mutational signatures associated with tobacco smoking in human cancer.
Ludmil B Alexandrov, Young Seok Ju, Kerstin Haase, Peter Van Loo, Iñigo Martincorena, Serena Nik-Zainal, Yasushi Totoki, Akihiro Fujimoto, Hidewaki Nakagawa, Tatsuhiro Shibata,[...]. Science 2016
524
3

UV radiation and the skin.
John D'Orazio, Stuart Jarrett, Alexandra Amaro-Ortiz, Timothy Scott. Int J Mol Sci 2013
662
3

The evolutionary history of 2,658 cancers.
Moritz Gerstung, Clemency Jolly, Ignaty Leshchiner, Stefan C Dentro, Santiago Gonzalez, Daniel Rosebrock, Thomas J Mitchell, Yulia Rubanova, Pavana Anur, Kaixian Yu,[...]. Nature 2020
317
3

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.
Christina Curtis, Sohrab P Shah, Suet-Feung Chin, Gulisa Turashvili, Oscar M Rueda, Mark J Dunning, Doug Speed, Andy G Lynch, Shamith Samarajiwa, Yinyin Yuan,[...]. Nature 2012
3

The clonal and mutational evolution spectrum of primary triple-negative breast cancers.
Sohrab P Shah, Andrew Roth, Rodrigo Goya, Arusha Oloumi, Gavin Ha, Yongjun Zhao, Gulisa Turashvili, Jiarui Ding, Kane Tse, Gholamreza Haffari,[...]. Nature 2012
3

The landscape of cancer genes and mutational processes in breast cancer.
Philip J Stephens, Patrick S Tarpey, Helen Davies, Peter Van Loo, Chris Greenman, David C Wedge, Serena Nik-Zainal, Sancha Martin, Ignacio Varela, Graham R Bignell,[...]. Nature 2012
3

Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2.
X Wu, K Hepner, S Castelino-Prabhu, D Do, M B Kaye, X J Yuan, J Wood, C Ross, C L Sawyers, Y E Whang. Proc Natl Acad Sci U S A 2000
324
3

NK cells for cancer immunotherapy.
Noriko Shimasaki, Amit Jain, Dario Campana. Nat Rev Drug Discov 2020
312
3


DNA double-strand break repair-pathway choice in somatic mammalian cells.
Ralph Scully, Arvind Panday, Rajula Elango, Nicholas A Willis. Nat Rev Mol Cell Biol 2019
413
3

Initial genome sequencing and analysis of multiple myeloma.
Michael A Chapman, Michael S Lawrence, Jonathan J Keats, Kristian Cibulskis, Carrie Sougnez, Anna C Schinzel, Christina L Harview, Jean-Philippe Brunet, Gregory J Ahmann, Mazhar Adli,[...]. Nature 2011
3

Initial sequencing and analysis of the human genome.
E S Lander, L M Linton, B Birren, C Nusbaum, M C Zody, J Baldwin, K Devon, K Dewar, M Doyle, W FitzHugh,[...]. Nature 2001
3

Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma.
Georgina V Long, Axel Hauschild, Mario Santinami, Victoria Atkinson, Mario Mandalà, Vanna Chiarion-Sileni, James Larkin, Marta Nyakas, Caroline Dutriaux, Andrew Haydon,[...]. N Engl J Med 2017
751
3

Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing.
Isidro Cortés-Ciriano, Jake June-Koo Lee, Ruibin Xi, Dhawal Jain, Youngsook L Jung, Lixing Yang, Dmitry Gordenin, Leszek J Klimczak, Cheng-Zhong Zhang, David S Pellman,[...]. Nat Genet 2020
181
3


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.